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Emerging Infectious 
Diseases
Donna Gallagher,
PhD, ANP-C,MS, FAAN
PI, NEAETC
Lancet
recent emerging diseases
Emerging and re-emerging infectious 
diseases
• AIDS
• Avian Influenza
• Ebola
• Marburg
• Cholera
• Rift Valley Fever
• Typhoid 
• Lassa Fever
• Tuberculosis
• Leptospirosis
• Malaria
• Japanese 
encephalitis
• Chikungunya
• Dengue
• Antimicrobia
l resistance
• MERS
Factors contributing to emergence
AGENT
• Evolution of pathogenic infectious 
agents (microbial adaptation & 
change)
• ex: influenza
• Development of resistance to drugs 
• ex: MRSA, KPC
• Resistance of vectors to pesticides
• ex: malaria
Factors contributing to emergence
HOST
» Human demographic change (inhabiting new 
areas)
» Human behaviour (sexual & drug use)
» Human susceptibility to infection 
(Immunosuppression)
» Poverty & social inequality
Factors contributing to emergence
ENVIRONMENT
»Climate & changing ecosystems
»Economic development & Land use 
(urbanization, deforestation)
»Technology & industry (food processing 
& handling)
Transmission of Infectious Agent from 
Animals to Humans
• Emerging Influenza infections in Humans associated 
with Geese, Chickens & Pigs
• Animal displacement in search of food after 
deforestation/ climate change (Lassa fever)
• Humans themselves penetrate/ modify unpopulated 
regions- come closer to animal reservoirs/ vectors 
(Yellow fever, Malaria)
Dr. KANUPRIYA CHATURVEDI
Emerging Zoonoses: Human-animal 
interface
Marburg virus
Hantavirus Pulmonary 
Syndrome
Ebola virus
Borrelia burgdorferi: Lyme Deer tick
Mostomys
rodent: Lassa 
fever
Avian influenza 
virus
Bats: Nipah
virus
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How Ebola  Outbreaks Start
●First human cases start with infection by an animal 
●Bats to chimpanzes, other animals and bush meat. How current 
outbreak started in unknown, but killing and preparing bush meat can 
spread other viral illnesses
●Infection from person-to-person creates an outbreak
• Direct or indirect physical contact with body fluids of a sick
infected person (blood, saliva, vomitus, urine, stool, semen)
●Well known locations where transmission occurs
• Hospital: 
• Health care workers, other patients, unsafe injections
• Houses and Communities:
• Family, friends, contacts caring for ill, through funeral 
practices---ie contact with dead bodies
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Critical Issues
● First  large Ebola outbreak in West Africa
● Underlying weakness in health systems
● Lack of preparedness and poor surveillance, health 
care, diagnostics, communications … 
• Health worker infections  & inadequate infection 
control & prevention The affected countries in West Africa 
have some of the worst physician–patient ratios in the world:
– Liberia: more than 86 000 patients per physician
– Sierra Leone: more than 45 000 patients per physician
Effect of fear 
● Strong community resistance in places ……..
Training ………… screening
PPE, Bleach water (0.5% and 
0.05%) Triage, Isolation, and No 
Touch Care!
Lab tech in the clinic MOH Triage Flow Chart USA PPE
US
• Contact Precautions
• Working knowledge of emerging diseases
• Know  where your PPE is located
• Know who to call
• Don’t Panic
EMERGING INFECTIONS: STANDARD 
AND TRANSMISSION-BASED 
PRECAUTIONS FOR AMBULATORY 
HEALTHCARE SETTINGS
Kathy Eklund RDH, MHP
The Forsyth Institute
keklund@forsyth.org
Disclosures
Disclosure: Neither I nor members of my 
immediate family have any financial relationships 
with commercial entities that may be relevant to 
this presentation.
Visuals of products and devices are examples and 
are  not an endorsement.
Objectives 
• Differentiate standard and transmission-based  precaution 
measures
• Identify measures and resources clinicians may use to 
promote respiratory hygiene and setting-specific illness 
recognition.
What is  an Infection Prevention and  
Control Program?
A system of policies, procedures and practices 
that when successfully implemented, will 
minimize the risk of transmission of 
pathogenic microorganisms.  The goal is to 
prevent: 
– healthcare-associated infections in patients
– injuries and illnesses in healthcare personnel 
Public Trust & Expectations
Infection Prevention and Control Program
Professional 
Standards, Best 
Practices
Regulations, 
Guidance,  
Standards 
Individual
Provider,
Practice,
Institution
(SOPs, 
Ethics)
Patient 
&
Personnel 
Safety
Infection Control Policies and 
Procedures..
• Should be supported by an authoritative source
The Chain of Infection
Standard Precautions
Sterilization
Vaccination
Hand Hygiene 
PPE
Portal of Entry
Mucos Membrane         GI Tract
Respiratory     Broken Skin
Pathogens of Sufficient 
Virulence and Numbers 
to Cause Infection
Susceptible Host
One who is not immune
Mode of Transmission
Direct or indirect Contact    
Droplet Airborne
Reservoir or Source
Blood, Water
Break the Chain
Summary
 A variety of infectious agents can be transmitted in 
ambulatory healthcare settings through contact, 
droplet and airborne modes
 Standard precautions remain the major infection 
prevention strategy to prevent transmissions
 Hepatitis B and C virus transmission in healthcare 
remain preventable risks
Standard Precautions
• Synthesize major features of Universal Precautions
– Applies to all patients regardless of diagnosis or infection 
status
– Includes blood and all body fluids except sweat (includes 
saliva in all settings)
• May be supplemented by special isolation precautions for 
diseases transmitted by contact, droplet or airborne 
routes
Guideline for Isolation Precautions in Hospitals
Epidemiol 1996;17:53-80, and Am J Infect Control 1996;24:24-52. 
Standard Precautions
• MUST be used in the care of all patients 
regardless of their infection status.
• Some patients require additional measures 
= ‘transmission-based precautions’
– Interrupt potential spread of diseases via 
airborne, droplet, or contact transmission.
– e.g. TB, influenza, and chickenpox
– Spread via coughing, sneezing or contact with 
skin.
CDC 2007 Guideline for Isolation Precautions
http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. 
Transmission-Based Precautions 
Pathogen and syndrome-based precautions, 
termed transmission-based precautions, for 
the care of patients who are infected or 
colonized with pathogens spread through 
airborne, droplet, or contact routes.
• Standard Precautions +….. 
CDC 2007 Guideline for Isolation Precautions
http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. 
Guidelines for infection control in dental health-care settings—2003. 
http://www.cdc.gov/mmwr/PDF/rr/rr5217.pdf
Standard Precautions +
TRANSMISSION-BASED PRECAUTIONS 
• Transmission-based precautions are designed 
for patients documented or suspected to be 
infected or colonized with pathogens that 
require additional precautions beyond the 
standard precautions necessary to interrupt 
transmission. 
• These precautions apply to airborne, droplet, 
and contact transmissions. The precautions
may be combined for diseases that have 
multiple routes of transmission. 
• Whether singly or in combination, they are 
always to be used in addition to standard 
precautions.
Transmission-Based Precautions
• Might include:
• Patient placement (e.g., isolation)
• Adequate room ventilation
• Respiratory protection (e.g., N-95 masks) for dental 
health-care personnel (DHCP)
• Postponement of nonemergency dental procedures.
• More than 1 transmission category may apply
• Always used IN ADDITION to Standard 
Precautions
CDC 2007 Guideline for Isolation Precautions
http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. 
Guidelines for infection control in dental health-care settings—2003. 
http://www.cdc.gov/mmwr/PDF/rr/rr5217.pdf
Contact Precautions
Contact transmission, the 
most important and 
frequent mode of 
transmission of 
heahcare-associated 
infections, is divided into 
two subgroups: 
direct-contact 
transmission
indirect-contact 
transmission
Example:  MRSA
Contact: Droplet Precautions
• Droplet transmission, 
theoretically, is a form of 
contact transmission. 
However, the 
mechanism of transfer 
of the pathogen to the 
host is quite distinct 
from either direct- or 
indirect-contact 
transmission. Therefore, 
droplet transmission is 
considered a separate 
route of transmission
• Examples:
– Influenza
– Chickenpox
Airborne Precautions
• Airborne transmission
occurs by dissemination of 
either airborne droplet 
nuclei (small-particle 
residue [5 µm or smaller] of 
evaporated droplets 
containing microorganisms 
that remain suspended in 
the air for long periods) or 
dust particles containing 
the infectious agent.
• Tuberculosis (TB)  
2014 Ebola Outbreak Response
West Africa
• Centers for Disease 
Control and Prevention
• Ebola Response 2014
2014 Ebola 
Outbreak 
Healthcare Providers in the United States
 CDC encourages all U.S. healthcare providers to:
 Ask patients about their travel histories to determine if they have 
traveled to West Africa within the last three weeks
 Know the signs and symptoms of Ebola – fever (greater than 
100.4°F  or 38°C), severe headache, muscle pain, vomiting, diarrhea, 
abdominal (stomach) pain, or unexplained hemorrhage (bleeding 
or bruising)
 Know what to do if they have a patient with Ebola symptoms:
• First, properly isolate the patient
• Then, follow infection control precautions to prevent the 
spread of Ebola.  
• Avoid contact with blood and body fluids of infected people
Infection Control Principles
 Early recognition
 Early recognition is critical for infection control
 Patient Placement
 Patients should be placed in a single patient room containing a 
private bathroom with the door closed
 Protecting healthcare providers
 IDENTIFY-ISOLATE-INFORM
 Guidance for hospitals available at: 
http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-
control-recommendations.html
 Guidance for emergency departments available at: 
http://www.cdc.gov/vhf/ebola/hcp/ed-management-patients-
possible-ebola.html
 Guidance for ambulatory care settings in development
Elements of Standard Precautions
• Handwashing
• Personal protective equipment 
• Sterilization of instruments and devices
• Cleaning/disinfecting environmental surfaces
• Engineering/work practice controls
• Respiratory hygiene/cough etiquette
• Safe injection practices
CDC 2007 Guideline for Isolation Precautions
http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. 
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Immunization of Health-Care Personnel
2012 ACIP Adult Immunization Schedule, Medical, 
Occupational and Behavior-Based 
Recommendations
Recommended Vaccines for HCP Based on 
Risk of Healthcare Setting Transmission*
*MMWR November 25, 2011 / 60(RR07);1-45
Hepatitis B Give 3-dose series.  Give IM. Obtain anti-HBs serologic 
testing 1-2 months after dose #3
Influenza Give 1 dose of TIV or LAIV annually.  Give TIV 
intramuscularly or LAIV intranasally.  Follow 2013 
recommendations from CDC
MMR HCP born in 1957 or later without evidence of immunity 
or prior vaccination, give 2 doses MMR, 4 weeks apart.  
Give SC. If born before 1957, 1 dose. Two doses for all 
HCP during mumps outbreak.
Varicella HCP with no serologic proof of immunity, prior 
vaccination, or history of varicella disease, give 2 
doses of varicella vaccine, 4 weeks apart.  Give SC.
Tetanus/diph-
theria/pertussis
All HCP need Td every 10 years after completing a 
primary series. Give 1 dose of Tdap IM, if direct patient 
contact, prioritize HCP in contact with pts. <12 mos.  
39
CDC Recommendations for      
Hepatitis B Protection among HCP 
(2013)
www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm?s_cid=rr6210a1_w
HCP with Hepatitis B Vaccination 
in the Remote Past
40
 Increasing proportion of HCP entering training 
and workforce have received HepB vaccination 
as infants or in the remote past 
 Anti-HBs testing not recommended after routine infant 
HepB vaccination
 Anti-HBs after vaccination wanes over time, 
although protection believed to persist
HCP with Hepatitis B Vaccination 
in the Remote Past                               
(with Documentation of Complete, ≥3-dose HepB vaccine series) 
41
 May undergo anti-HBs testing upon hire or 
matriculation
 Anti-HBs ≥10 mIU/mL:  Considered immune
 Anti-HBs <10 mIU/mL:   1 additional dose of HepB
vaccine, followed by anti-HBs testing 1-2 months later
• HCP whose anti-HBs remains <10 mIU/mL should 
receive 2 additional doses (usually 6 doses total), 
followed by repeat anti-HBs testing 1-2 months after 
last dose
Pre-exposure anti-HBs Testing HCP 
Vaccinated in the Remote Past
42
 ~72% of institutions measure anti-HBs upon 
hire/matriculation for remotely vaccinated 
HCP 
 Advantages
 Results in fewer cases of occupational Hepatitis B 
transmission
 Provides greatest protection for HCP (including 
protection against unrecognized/unreported 
exposures)
 More cost-effective over time 
• 2013 MMWR
INFLUENZA VACCINE
Tools for the Prevention of Influenza
 Influenza vaccine
 Antiviral medications
 Can be used for treatment or prevention (prophylaxis)
 Hand hygiene
 Masks
 Respirators
 Environmental controls
 E.g. ensuring appropriate ventilation, air exchange, physical 
barriers, etc.
Influenza Vaccine
 Primary means for preventing 
influenza
 Recommended annually for all 
people 6 months of age and 
older
 Including pregnant women
 Including healthcare personnel
 “Insurance” against infection
 Benefit to those vaccinated plus 
decreases risk of spreading 
influenza to others
 Not 100% effective
 Need to use other tools in addition to 
vaccination
Influenza and Vaccination
 Four types of influenza vaccines available:
 Traditional inactivated (“killed”) influenza vaccine  
injected in muscle 
• anyone 6 months of age or older
 Nasal spray vaccine (LAIV): healthy individual
• ages 2-49 years
• HCP not working with patients in a protected environment
 High-dose inactivated injectable vaccine 
• 65 years and older 
 Intradermal inactivated vaccine: uses very small needle
• 18-64 years old
Influenza and Mask or Respirator Use
 Relatively few clinical studies done to assess reduction in influenza 
illness in clinical setting for masks or respirators
 Household transmission studies and one study of college students 
found 
 Limited reductions with mask +/- hand hygiene when
• High levels of compliance with mask use
• Early initiation of mask use
 No reductions in influenza with increase in hand hygiene alone
 Study of 2009 H1N1 in hospital workers
 Masks likely helpful
 Emergency Department workers more likely to become ill with 
influenza than other types of workers
• May have been related to lack of wearing mask with first 
encounter with patient
Apisarnthanarak CID 2012; Vanhems Archives Intern Med 2011; Aiello JID 2010;  Cowling Epi Infect 2010; Aiello AJPH 2008
Influenza vaccination coverage of health care 
personnel by occupation, mid-November 2011
† "Other" includes allied health professionals, technicians/assistants and aides, and 
administrative and non-clinical support staff.
Group Already vaccinated
Overall 63.4
Occupation:
Physician/dentist 77.6
Nurse practitioner/physician assistant 76.8
Nurse 75.7
Other† 58.7
http://www.cdc.gov/flu/professionals/vaccination/health-care-personnel.htm
Conclusions for Influenza
 Many tools for influenza prevention, but 
vaccination is the primary means to prevent 
influenza
 Best insurance against influenza infection and 
transmission to HCP family, friends, coworkers and 
patients
 Vaccination should be used in conjunction with 
other influenza prevention tools to most 
effectively decrease the spread of influenza
Common Reasons HCP and Adult Patients Might 
Give for Not Getting Vaccinated 
10. Vaccine preventable diseases are a thing of the past. 
9.  Vaccines don’t work.
8.  I  am great at washing my hands.
7.  I always put on a mask before I am near patients that may 
have [INSERT DISEASE HERE].
6.  I never come to work sick. 
5.   Vaccines will make me sick. 
4.  It is easier to deal with the rare case than to vaccinate 
routinely.
3.  My patients are already vaccinated so I don’t need to be.
2.  The healthcare facility where I work doesn’t require vaccines.
1.  My doctor didn’t recommend any vaccines for me.
Summary
 Outbreaks of vaccine preventable diseases 
continue to occur
 Result in health risks to patients and HCP and their 
families
 Very disruptive and expensive to investigate and 
manage
 Can be difficult to recognize early and before many 
people have been exposed
 Exposures and illnesses can result in substantial lost 
work time as early awareness and implementation of 
control measures challenging
Conclusions
 Vaccines have been highly successful in reducing the 
burden of many diseases
 Vaccination are a critical component of infection 
control to protect HCP and their patients, coworkers 
and families
 DHCP should be 
 Assessed for vaccination and immunity status at the 
time of hire and at least annually to ensure they are up 
to date with recommended vaccines.
 Provided with information about risks and benefits of 
the vaccines
Tuberculin Skin Test
TB Blood Test 
Identifies if  a person was 
exposed to MTB
Primed peptide TH1 cells 
create interferons
TB Testing Frequency
Risk category Frequency
Low Baseline on hire; further 
testing not needed unless 
exposure occurs
Medium Baseline, then annually
Potential ongoing 
transmission
Baseline, then every 8–10 
wks until evidence of 
transmission has ceased
Program Evaluation: Immunization 
of HCP
• Program Element
– Appropriate immunization of health-care personnel (HCP). 
• Develop and implement a program that promotes immunity of 
health-care personnel according to current CDC ACIP 
recommendations for health-care personnel. 
– HBV Vaccine:  OSHA Bloodborne Pathogens Standard Regulate Employer 
provide Education and Training, access to HBV vaccine during normal 
working hours, and pay for the vaccine. If employee refuses, the OSHA 
Declination form must be signed, but employee can change his/her mind.
– Other CDC recommended vaccines………
• Evaluation Activity
– Conduct an annual review of personnel records to ensure 
up-to-date immunizations.
• Keep updated immunization records of personnel.
• Refer non-immune personnel to a qualified health-care provider  
for evaluation and indicated vaccinations/immunizations.
Work Restrictions of HCP
Medical Conditions, Work-Related Illness, 
and Work Restrictions
• HCP are responsible for monitoring their own health 
status. HCP who have acute or chronic medical 
conditions that render them susceptible to 
opportunistic infection should discuss with their 
personal physicians or other qualified authority 
whether the condition might affect their ability to 
safely perform their duties.
• Under certain circumstances, health-care facility 
managers might need to exclude HCP from work or 
patient contact to prevent further transmission of 
infection  (e.g.,  conjunctivitis, influenza, etc.) 
Medical Conditions, Work-Related Illness, and 
Work Restrictions
• Under certain circumstances, health-care facility 
managers might need to exclude HCP from work or 
patient contact to prevent further transmission of 
infection  (e.g.,  conjunctivitis, influenza, etc.) 
• Managers may exclude HCP from patient contact to 
prevent transmission
– Work restrictions based on mode of transmission 
and period of infectivity
– Written policies should define who can exclude HCP 
(e.g., personal physicians) and be clearly 
communicated 
Medical Conditions, Work-Related Illness, and 
Work Restrictions
Decisions concerning work restrictions are 
based on the mode of transmission and the 
period of infectivity of the disease. 
Medical Conditions, Work-Related Illness and Work 
Restrictions
• Exclusion policies should 
– 1) be written, 
– 2) include a statement of authority that defines 
who can exclude DHCP (e.g., personal 
physicians), and 
– 3) be clearly communicated through education 
and training. Policies should also encourage 
DHCP to report illnesses or exposures without 
jeopardizing wages, benefits, or job status.
Medical Conditions, Work-Related 
Illness and Work Restrictions
Policies should 
encourage DHCP 
to report illnesses 
or exposures 
without 
jeopardizing 
wages, benefits, or 
job status.
Work Restrictions: Influenza
• Self-assess daily for symptoms 
of febrile respiratory illness 
(fever plus one or more of the 
following: 
– nasal congestion/runny 
nose, 
– sore throat 
– cough.
• Personnel who develop fever 
and respiratory symptoms 
should promptly notify their 
supervisor and should not 
report to work.
Work Restrictions - Influenza
Personnel should remain 
at home until at least 24 
hours after they are free 
of fever (100°F/37.8°C), or 
signs of a fever, without 
the use of fever-reducing 
medications.
Resource:  Preventing Transmission of Influenza  
in  Healthcare Settings 
• http://www.cdc.gov/flu/pdf/infectioncontrol_seaso
nalflu_ICU2010.pdf
• On July 29, 2010, CDC issued Recommendations for 
the Prevention and Control of Influenza
• http://www.cdc.gov/flu/professionals/infectioncont
rol/healthcaresettings.htm
• http://www.cdc.gov/flu/professionals/infectioncont
rol/
Diseases for Which Vaccines Routinely 
Recommended for HCP and Work Implications if 
Exposed* or Infected
Measles Mumps Rubella Varicella Pertussis
if exposed 
and not 
immune
5 days after 
exposure 
through 21 
days
12 days 
after
exposure 
through 25 
days
7 days after 
exposure
through 23 
days
8 days after 
exposure
through 
21/28 
days**
Monitor for 
cough for 
21 days; 
consider 
antibiotics
if ill For 4 days 
after rash
first 
appears
For 5 days 
after onset 
parotitis
For 7 days 
after rash 
first 
appears
Until all 
lesions dry
and crust or 
no new 
lesions >24 
hours
3 weeks 
after cough 
onset or 5 
days 
antibiotics
Vaccine 
Doses***
2 SQ MMR 
doses
2 SQ MMR 
doses
1 SQ MMR 
dose
2 SQ One Tdap
as adult
*Exposures are from first exposure through date of last exposure. **Longer if receive immune globulin; 
***for MMR and Varicella is no accepted evidence of immunity.
CDC.  Immunization of Health-care Personnel:  Recommendations of the Advisory Committee on 
Immunization Practices.  MMWR 2011;60:RR1-47.
Program Evaluation: Immunization 
of DHCP
• Program Element
– Appropriate immunization of dental health-care 
personnel (DHCP). 
• Develop and implement a program that promotes immunity of 
health-care personnel according to current CDC ACIP 
recommendations for health-care personnel. 
– HBV Vaccine:  OSHA Bloodborne Pathogens Standard Regulate Employer 
provide Education and Training, access to HBV vaccine during normal 
working hours, and pay for the vaccine. If employee refuses, the OSHA 
Declination form must be signed, but employee can change his/her mind.
– Other CDC recommended vaccines………
• Evaluation Activity
– Conduct an annual review of personnel records to 
ensure up-to-date immunizations.
• Keep updated immunization records of personnel.
• Refer non-immune personnel to a qualified health-care 
provider  for evaluation and indicated 
vaccinations/immunizations.
Hand Hygiene/Antisepsis for 
Routine Dental Procedures
Soap & 
Water
Anti-microbial 
Soap & Water
Alcohol-based 
Hand Rub 
Alone
If hands are visibly 
soiled with blood, 
body fluids, or 
proteinaceous 
material
YES YES NO
If hands are not
visibly soiled YES YES YES 

In the News…
December 13, 2013
70
• FDA issues proposed rule to determine safety and 
effectiveness of over the counter antibacterial soaps  
– http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce
ments/ucm378542.htm
– proposed rule to require manufacturers of antibacterial 
hand soaps and body washes to demonstrate that their 
products are safe for long-term daily use and more effective 
than plain soap and water in preventing illness and the 
spread of certain infections. 
– Under the proposal, if companies do not demonstrate such 
safety and effectiveness, these products would need to be 
reformulated or relabeled to remain on the market.
Hand Hygiene/Antisepsis
Surgical Procedures
Soap & 
Water 
Alone
Antiseptic 
Handwash*
& Water
Antiseptic 
Handwash & 
Water Followed 
by Alcohol-
based Hand 
Rub*
Surgical hand 
antisepsis prior to 
gloving
NO YES YES
* Antiseptic handwash agent and alcohol-based hand 
rubs should have a persistent effect and broad 
spectrum of activity, and be fast-acting.
PPE 
• Wear long-sleeved 
disposable or reusable 
gowns, lab coats, or 
uniforms that cover 
skin and personal 
clothing likely to be 
soiled with blood, saliva 
or infectious material
• Change if visible soiled, 
or as soon as possible
• Remove all barriers 
before leaving patient 
care or laboratory areas
72
73http://www.cdc.gov/vhf/ebola/pdf/ppe-poster.pdf
New Elements to Standard 
Precautions (2007)
• ‘Infection control problems that are identified in 
the course of outbreak investigations often 
indicate the need for new recommendations or 
reinforcement of existing infection control 
recommendations to protect patients.’
• Two areas of practice relevant to dentistry added:
– Respiratory Hygiene/Cough Etiquette
– Safe Injection Practices
CDC 2007 Guideline for Isolation Precautions
http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. 
Respiratory Hygiene/Cough Etiquette
• Grew out of observations during severe acute 
respiratory syndrome (SARS) outbreaks where 
failures to implement simple source control 
measures with patients, visitors, and health-care 
personnel with respiratory symptoms may have 
contributed to SARS-coronavirus (SARS-CoV) 
transmission.
• Conclusions of the investigations of transmissions 
that could have been prevented by adherence to 
basic principals of aseptic technique for the 
preparation and administration of parenteral 
medications
Safe Injection Practices
Respiratory Hygiene/Cough Etiquette
• Cover your mouth and 
nose with a tissue when 
coughing or sneezing;
• Use in the nearest waste 
receptacle to dispose of 
the tissue after use;
• Perform hand hygiene 
after having contact with 
respiratory secretions and 
contaminated 
objects/materials.
http:///www.cdc.gov/flu/professionals/infectioncontrol/resphygiene.htm
Supplies for Patient Areas 
 Kleenex
 Hand sanitizer
 Masks – specifications 
and proper use
• Identify patients 
with signs and 
symptoms of fever 
and cough.
• Place symptomatic 
patients in separate 
room.
• Give patient 
surgical face mask
• Contact providers 
should wear at 
least  surgical face 
mask.
http://www.health.state.mn.us/divs/idepc/dtopics/infectioncontrol/cover/hcp/notice.pdf
Safe Injection Practices
• Safe Injection Practices are a set 
of recommendations within 
Standard Precautions, which are 
the foundation for preventing 
transmission of infections 
during patient care in all 
healthcare settings
Note: In dentistry, generally applies to 
administration of parenteral 
medications not related to local 
anesthesia.
http://www.cdc.gov/injectionsafety/IP07_standardPrecaution.html
Risk of Infection after Needlestick
Source
HBV
HBeAg+
HBeAg-
HCV
HIV
Risk
6.0-30.0%
22.0-30.0%
1.0-6.0%
1.8%
0.3%
1/3
1/300
1/30
Safe Injection Practices = Aseptic 
Technique for Parenteral Medications
• Do not administer medications from a syringe to 
multiple patients, even if the needle on the syringe is 
changed (IA) (378).
• Use single-dose vials for parenteral medications when 
possible (II) (376,377).
• Do not combine the leftover contents of single-use vials 
for later use (IA) (376,377).
• Use fluid infusion and administration sets (i.e., IV bags, 
tubing and connections) for one patient only and 
dispose of appropriately (IB) (378).
CDC 2007 Guideline for Isolation Precautions
http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf. 
Guidelines for infection control in dental health-care settings—2003. 
http://www.cdc.gov/mmwr/PDF/rr/rr5217.pdf
Environmental Surfaces
Clinical Contact Housekeeping
Environmental Stability
• HBV can survive in dried blood on environmental 
surfaces for at least one week.
• In vitro studies have shown the HCV can remain 
infective on dry surfaces for up to 6 weeks.
• HBV and HCV transmission via contact with 
environmental surfaces has been demonstrated in 
investigations of outbreaks among patients and 
staff of hemodialysis units.
Bond WW et al, Lancet 1981
Kamili S et al, Infect Control Hosp Epidemiol 2007
Paintsil E, J Infect Dis 2014.
• Remove
• Replace
• Spray
• Clean/wipe
• Spray
Barriers         VS.  Cleaning and 
Disinfection
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Clean and disinfect using an EPA 
registered low- ( HIV/HBV claim) to 
intermediate- (tuberculocidal claim) 
level hospital disinfectant
Premoistened Disinfectant Wipes
• Wipe (clean)
• Wipe (disinfect)
• Wait (manufacturer’s 
claim)
• Follow specific 
Product 
Manufacturer’s  
Instructions for use. 
Principle 4
Make Reusable Patient Care Items Safe for Use
• Clean, heat sterilize or 
disinfect reusable 
patient care items that 
….
• Monitor processes….
• Contain and dispose 
of single use items
• Considerations for on-
site vs. centralized 
processing of re-
usable patient care 
items.
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Proper Work Flow Prevents Errors
“Program evaluation provides an 
opportunity to identify and change 
inappropriate practices, thereby 
improving the effectiveness of your 
infection control program.”
• Centers for Disease Control (CDC) “Guidelines for Infection 
Control in Dental Health-Care Settings – 2003” 
Implementing Change
Proactive
Reactive
Program Evaluation
• Strategies and Tools
–Periodic observational 
assessments
–Checklists to document 
procedures
–Routine review of 
occupational 
exposures to 
bloodborne pathogens 
Checklists for Repeatable 
Processes
• Remind individuals of 
critical steps to complete 
each time
• Provide verification that 
the steps have been 
completed
• Create a history that can 
be reconstructed if there 
is an adverse event
2011
Guide and Checklist for Outpatient Settings
http://www.cdc.gov/HAI/settings/outpatient/outpatient-settings.html
2011 Guide Summary
 Basic infection prevention recommendations for 
outpatient settings
 Administrative measures
• Education and training of all HCP
• Report process and outcome measures
 Standard Precautions
 Hand hygiene PPE
 Injection safety Environmental cleaning
 Medical equipment Resp hygiene/cough etiquette
 Resources
 Disinfection and sterilization
 FDA device information
 Transmission based precautions
Checklist for Infection Prevention for 
Outpatient Settings
Thank You
